These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29485748)

  • 21. HIV/AIDS workplace policy addressing epidemic drivers through workplace programs.
    Chatora B; Chibanda H; Kampata L; Wilbroad M
    BMC Public Health; 2018 Jan; 18(1):180. PubMed ID: 29370779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychosocial and behavioral factors associated with risk of sexually transmitted diseases, including human immunodeficiency virus infection, among urban high school students.
    Shafer MA; Boyer CB
    J Pediatr; 1991 Nov; 119(5):826-33. PubMed ID: 1941394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global AIDS Reporting-2001 to 2015: Lessons for Monitoring the Sustainable Development Goals.
    Alfvén T; Erkkola T; Ghys PD; Padayachy J; Warner-Smith M; Rugg D; de Lay P
    AIDS Behav; 2017 Jul; 21(Suppl 1):5-14. PubMed ID: 28124296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying structural barriers to an effective HIV response: using the National Composite Policy Index data to evaluate the human rights, legal and policy environment.
    Gruskin S; Ferguson L; Alfven T; Rugg D; Peersman G
    J Int AIDS Soc; 2013 Apr; 16(1):18000. PubMed ID: 23621903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human immunodeficiency virus in Cuba: the public health response of a Third World country.
    Santana S; Faas L; Wald K
    Int J Health Serv; 1991; 21(3):511-37. PubMed ID: 1917211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A global review of legislation on HIV/AIDS: the issue of HIV testing.
    D'Amelio R; Tuerlings E; Perito O; Biselli R; Natalicchio S; Kingma S
    J Acquir Immune Defic Syndr; 2001 Oct; 28(2):173-9. PubMed ID: 11588512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malaysia and harm reduction: the challenges and responses.
    Reid G; Kamarulzaman A; Sran SK
    Int J Drug Policy; 2007 Mar; 18(2):136-40. PubMed ID: 17689356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact and Cost of the HIV/AIDS National Strategic Plan for Mozambique, 2015-2019--Projections with the Spectrum/Goals Model.
    Korenromp EL; Gobet B; Fazito E; Lara J; Bollinger L; Stover J
    PLoS One; 2015; 10(11):e0142908. PubMed ID: 26565696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the Southern Harm Reduction Coalition for HIV Prevention: Advocacy Accomplishments.
    Story CR; ; Kao WK; Currin J; Brown C; Charles V
    Health Promot Pract; 2018 Sep; 19(5):695-703. PubMed ID: 29186992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can Social Protection Improve Sustainable Development Goals for Adolescent Health?
    Cluver LD; Orkin FM; Meinck F; Boyes ME; Yakubovich AR; Sherr L
    PLoS One; 2016; 11(10):e0164808. PubMed ID: 27749932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Harm reduction, HIV/AIDS, and the human rights challenge to global drug control policy.
    Elliott R; Csete J; Wood E; Kerr T
    Health Hum Rights; 2005; 8(2):104-38. PubMed ID: 17136905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reviewing independent access to HIV testing, counselling and treatment for adolescents in HIV-specific laws in sub-Saharan Africa: implications for the HIV response.
    Eba PM; Lim H
    J Int AIDS Soc; 2017 Aug; 20(1):21456. PubMed ID: 28799324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and correlates of HIV infection among people who use drugs in Cambodia: a cross-sectional survey using respondent driven sampling method.
    Tuot S; Mburu G; Mun P; Chhoun P; Chann N; Prem K; Yi S
    BMC Infect Dis; 2019 Jun; 19(1):515. PubMed ID: 31185925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the Impact of a Human Rights-Based Approach across a Spectrum of Change for Women's, Children's, and Adolescents' Health.
    Thomas R; Kuruvilla S; Hinton R; Jensen SL; Magar V; Bustreo F
    Health Hum Rights; 2015 Dec; 17(2):11-20. PubMed ID: 26766852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Community organizations and fighting STDs, HIV and AIDS in Montreal: lessons for sub-Saharan Africa].
    Agonnoude MT; Mesenge C
    Sante; 2010; 20(2):116-24. PubMed ID: 20685643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Policy responses to HIV/AIDS in Central Asia.
    Ancker S; Rechel B
    Glob Public Health; 2015; 10(7):817-33. PubMed ID: 26189875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Living and dying to be counted: What we know about the epidemiology of the global adolescent HIV epidemic.
    Slogrove AL; Mahy M; Armstrong A; Davies MA
    J Int AIDS Soc; 2017 May; 20(Suppl 3):21520. PubMed ID: 28530036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "First, do no harm": legal guidelines for health programmes affecting adolescents aged 10-17 who sell sex or inject drugs.
    Conner B
    J Int AIDS Soc; 2015; 18(2 Suppl 1):19437. PubMed ID: 25724508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Executive summary: opportunities for action and impact to address HIV and AIDS in adolescents.
    Kasedde S; Kapogiannis BG; McClure C; Luo C
    J Acquir Immune Defic Syndr; 2014 Jul; 66 Suppl 2():S139-43. PubMed ID: 24918589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heroin Use and Injection Risk Behaviors in Colombia: Implications for HIV/AIDS Prevention.
    Mateu-Gelabert P; Harris S; Berbesi D; Segura Cardona ÁM; Montoya Vélez LP; Mejía Motta IE; Jessell L; Guarino H; Friedman SR
    Subst Use Misuse; 2016 Jan; 51(2):230-40. PubMed ID: 26800352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.